Insider Transactions in Q1 2020 at Procter & Gamble CO (PG)
Insider Transaction List (Q1 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2020
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
260
+0.98%
|
-
|
|
Mar 10
2020
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
249
+0.58%
|
-
|
|
Mar 10
2020
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
249
+1.3%
|
-
|
|
Mar 10
2020
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
208
+1.21%
|
-
|
|
Mar 10
2020
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
249
+11.46%
|
-
|
|
Mar 10
2020
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
291
+0.36%
|
-
|
|
Mar 10
2020
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
312
+0.92%
|
-
|
|
Feb 28
2020
|
Steven D Bishop CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
3,697
+8.27%
|
-
|
|
Feb 28
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
BUY
Grant, award, or other acquisition
|
Direct |
6,241
+9.79%
|
-
|
|
Feb 28
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Indirect |
604
+7.64%
|
-
|
|
Feb 28
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,728
+5.59%
|
-
|
|
Feb 28
2020
|
Carolyn M Tastad CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
3,622
+5.97%
|
-
|
|
Feb 28
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
2,509
+18.59%
|
-
|
|
Feb 28
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Direct |
11,255
+17.76%
|
-
|
|
Feb 28
2020
|
David S Taylor Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
30,359
+11.12%
|
-
|
|
Feb 28
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
BUY
Grant, award, or other acquisition
|
Direct |
14,785
+13.53%
|
-
|
|
Feb 28
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
14,061
-6.21%
|
$1,546,710
$110.44 P/Share
|
|
Feb 28
2020
|
Peltz Nelson Director |
SELL
Other acquisition or disposition
|
Indirect |
113,753
-0.37%
|
$12,854,089
$113.23 P/Share
|
|
Feb 28
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
1,641
-2.98%
|
$180,510
$110.44 P/Share
|
|
Feb 28
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
1,041
-10.94%
|
$114,510
$110.44 P/Share
|
|
Feb 28
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
4,311
-9.55%
|
$474,210
$110.44 P/Share
|
|
Feb 28
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Open market or private sale
|
Direct |
2,275
-2.77%
|
$250,250
$110.44 P/Share
|
|
Feb 28
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
387
-5.46%
|
$42,570
$110.44 P/Share
|
|
Feb 28
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
3,185
-2.53%
|
$350,350
$110.44 P/Share
|
|
Feb 28
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
2,213
-4.14%
|
$243,430
$110.44 P/Share
|
|
Feb 27
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Open market or private sale
|
Direct |
1,213
-5.46%
|
$141,921
$117.49 P/Share
|
|
Feb 27
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
5,297
-8.78%
|
$619,749
$117.49 P/Share
|
|
Feb 27
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
633
-6.24%
|
$74,061
$117.49 P/Share
|
|
Feb 27
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
2,343
-4.93%
|
$274,131
$117.49 P/Share
|
|
Feb 27
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Open market or private sale
|
Direct |
2,687
-3.17%
|
$314,379
$117.49 P/Share
|
|
Feb 27
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
688
-8.85%
|
$80,496
$117.49 P/Share
|
|
Feb 27
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
3,451
-2.67%
|
$403,767
$117.49 P/Share
|
|
Feb 27
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
2,738
-4.87%
|
$320,346
$117.49 P/Share
|
|
Feb 21
2020
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-80.84%
|
$1,270,000
$127.41 P/Share
|
|
Feb 21
2020
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.7%
|
$630,000
$63.05 P/Share
|
|
Feb 21
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Open market or private sale
|
Direct |
19,023
-46.15%
|
$2,396,898
$126.0 P/Share
|
|
Feb 21
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,023
+31.58%
|
$1,274,541
$67.52 P/Share
|
|
Feb 21
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
19,077
-71.05%
|
$2,422,779
$127.32 P/Share
|
|
Feb 21
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
19,077
+41.54%
|
$1,449,852
$76.18 P/Share
|
|
Feb 21
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
127,987
-49.72%
|
$16,254,349
$127.31 P/Share
|
|
Feb 21
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
127,987
+33.21%
|
$9,727,012
$76.18 P/Share
|
|
Feb 21
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
74,520
-24.76%
|
$9,464,040
$127.3 P/Share
|
|
Feb 21
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
74,520
+19.85%
|
$5,887,080
$79.05 P/Share
|
|
Feb 21
2020
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
3,000
-51.19%
|
$381,000
$127.75 P/Share
|
|
Feb 21
2020
|
Peltz Nelson Director |
SELL
Other acquisition or disposition
|
Indirect |
1,006,112
-3.13%
|
$126,770,112
$126.7 P/Share
|
|
Jan 28
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
37,385
-22.31%
|
$4,710,510
$126.28 P/Share
|
|
Jan 28
2020
|
Carolyn M Tastad CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
37,385
+17.64%
|
$2,916,030
$78.86 P/Share
|
|
Jan 27
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
58,297
-20.52%
|
$7,287,125
$125.93 P/Share
|
|
Jan 27
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
58,297
+17.03%
|
$4,430,572
$76.18 P/Share
|
|
Jan 24
2020
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
3,000
-43.76%
|
$378,000
$126.5 P/Share
|